RO5185426

· Hoffmann-La Roche

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for RO5185426, covering 2015-08-07 to 2016-02-11. Get the full timeline:

Most recent: Clinical Trial Update: A Study of RO5185426 in Patients With Metastatic Melanoma [Phase 2]